Recro to Present at Oppenheimer Fall Healthcare Life Sciences & Medtech Summit
GAINESVILLE, Ga., Sept. 18, 2020 (GLOBE NEWSWIRE) — Recro (Nasdaq:REPH), a leading contract development and manufacturing organization (CDMO), with integrated […]
Veru Announces ESMO Congress 2020 Oral Presentation of Positive Clinical Results from its VERU-111 Phase 1b Study in Metastatic Prostate Cancer
—Advancing VERU-111 to a Pivotal Phase 3 Clinical Program—MIAMI, Sept. 18, 2020 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), an […]
Progenity Announces Addition to Russell 2000® Index
SAN DIEGO, Sept. 18, 2020 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record […]
Vitru Limited Announces Pricing of Initial Public Offering
FLORIANÓPOLIS, Brazil, Sept. 18, 2020 (GLOBE NEWSWIRE) — Vitru Limited (“Vitru”), a Brazilian distance learning education group company, today announced […]
Summit Announces Effectiveness of Scheme of Arrangement and Completion of Redomiciliation to Delaware, USA
Summit Therapeutics Inc.(“Summit” or the “Company”)Summit Announces Effectiveness of Scheme of Arrangement and Completion of Redomiciliation to Delaware, USACambridge, MA, […]
Cardlytics Announces Pricing of Offering of $200 Million of Convertible Senior Notes
ATLANTA, Sept. 18, 2020 (GLOBE NEWSWIRE) — Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks’ digital channels, today announced […]
Checkmate Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides an Update on Recent Progress
Successfully completed IPO in August 2020 raising $76.6 million in gross proceedsOn track to initiate planned new clinical trials in […]
LGI Homes Introduces a Lineup of Brand-New Homes in the City of Palm Bay, Florida
PALM BAY, Fla., Sept. 18, 2020 (GLOBE NEWSWIRE) — LGI Homes, Inc. (Nasdaq:LGIH) today announced the introduction of brand-new, single-family homes […]
RenalytixAI Reaches Milestone of KidneyIntelX Commercial Testing with Mount Sinai Health System
NEW YORK, Sept. 18, 2020 (GLOBE NEWSWIRE) — Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro […]
Ayala Pharmaceuticals Presents Positive Interim Data from Phase 2 ACCURACY Trial of AL101 for the treatment of Recurrent/Metastatic Adenoid Cystic Carcinoma with Notch Activating Mutations at ESMO 2020
– Interim data showed meaningful clinical activity of AL101 4mg monotherapy with deep responses and 68% disease control rate– Company to host […]
